Bottom line
What is DRFAX's expense ratio?
DRFAX's expense ratio is 0.68%, or about $68 a year on every $10,000 invested. That is cheaper than 63% of large blend funds we track (median 0.83%). This share class also charges a front-end sales load of up to 4.75%, taken from your investment when you buy.
Updated Nov 26, 2025
DRFAX fee table
| Net expense ratio | 0.68% |
|---|---|
| Gross expense ratio | 0.68% |
| Management fee | 0.55% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.13% |
| Max front-end sales load | 4.75% |
| Max deferred sales charge | 0% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Nov 26, 2025
What DRFAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| DRFAX | $541 | $682 | $836 | $1,281 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.68% expense ratio costs roughly $38,700 in lost growth, versus about $46,700 for the median large blend fund (0.83%).